Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2793-2802

  Montano, Monty ^a   Flanagan, John N ^a   Jiang, Lan ^a   Sebastiani, Paola ^b   Rarick, Matthew ^a   Lebrasseur, Nathan K ^a   Morris, Carl A ^a   Jasuja, Ravi ^a   Bhasin, Shalender ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; BODY MASS; CELL CULTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ARTICLE; DNA MICROARRAY; DUAL ENERGY X RAY ABSORPTIOMETRY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SELECTION; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOREGULATION; LEAN BODY WEIGHT; MALE; METABOLISM; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UPREGULATION; WASTING SYNDROME; WEIGHT GAIN; WEIGHT REDUCTION; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34447120211     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2722     Document Type: Article

References (54)

1. Grinspoon S, Mulligan K; Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and Weight Loss 2003 Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 36:S69-S78
2. Coodley GO, Loveless MO, Merrill TM 1994 The HIV wasting syndrome: a review. J Acquir Immune Defic Syndr 7:681-694
3. Grunfeld C, Feingold KR 1992 Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 327:329-337
4. Tang AM 2003 Weight loss, wasting, and survival in HIV-positive patients: current strategies. AIDS Read 13:S23-S27
5. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL 2000 Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 31:803-805
6. Brodsky IG, Balagopal P, Nair KS 1996 Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: a clinical research center study. J Clin Endocrinol Metab 81:3469-3475
7. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnell TJ, Casaburi R 1997 Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 82:407-413
8. Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD, Beall G 2000 Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283:763-770
9. Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S 2004 Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab 89:5245-5255
10. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S 2003 Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144:5081-5088
11. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB 2002 Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589-598
12. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR 2001 Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724-731
13. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R 1996 The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335:1-7
14. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S 2006 Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community dwelling, older men. J Clin Endocrinol Metab 91:3024-3033
15. Sinha-Hikim I, Roth SM, Lee MI, Bhasin S 2003 Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 285:E197-E205
16. Welle S, Brooks A, Thornton CA 2001 Senescence-related changes in gene expression in muscle: similarities and differences between mice and men. Physiol Genomics 5:67-73
17. Ramoni MF, Sebastiani P, Kohane IS 2002 Cluster analysis of gene expression dynamics. Proc Natl Acad Sci USA 99:9121-9126
18. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA 2003 Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70
19. Montano M, Rarick M, Sebastiani P, Brinkmann P, Navis A, Wester CW, Thior I, Essex M 2006 Gene expression profiling of HIV-1 infection and perinatal transmission in Botswana. Genes Immun 7:298-309
20. Montano M, Rarick M, Sebastiani P, Brinkmann P, Skefos J, Ericksen R 2006 HIV-1 burden influences host response to coinfection with Neisseria gonorrhoeae in vitro. Int Immunol 18:125-137
21. Applied Biosystems 1998 Absolute and relative quantitation. In: Gene-Amp 5700 User's Manual; A9-A11
22. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW 2001 Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:E1172-E1181
23. Keren A, Tamir Y, Bengal E 2006 The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 252:224-230
24. Glass DJ 2005 Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37:1974-1984
25. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ 2004 Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24:9295-9304
26. Gray A, Berlin JA, McKinlay JB, Longcope C 1991 An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol 44:671-684
27. Gray A, Feldman HA, McKinlay JB, Longcope C, Berlin JA 1991 Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73:1016-1025
28. Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G 1998 Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 83:3155-3162
29. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A 2000 Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 133:348-355
30. Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A 1998 Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 129:18-26
31. Bhasin S, Javanbakht M 1999 Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection? JPEN J Parenter Enteral Nutr 23:S195-S201
32. Layne MD, Farmer SR 1999 Tumor necrosis factor-α and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. Exp Cell Res 249:177-187
33. Adams GR 1998 Role of insulin-like growth factor-I in the regulation of skeletal muscle adaptation to increased loading. Exerc Sport Sci Rev 26:31-60
34. Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty Jr CL, Urban RJ 2001 Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans.AmJ Physiol Endocrinol Metab 280:E383-E390
35. Lee DK 2002 Androgen receptor enhances myogenin expression and accelerates differentiation. Biochem Biophys Res Commun 294:408-413
36. Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C 2004 Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine 25:27-32
37. Kardon G, Harfe BD, Tabin CJ 2003 A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. Dev Cell 5:937-944
38. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S 2006 Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with β-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147:141-154
39. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A 1995 Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269:E820-E826
40. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ 2002 Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282:E601-E617
41. Rando TA 2006 Stem cells, ageing and the quest for immortality. Nature 441:1080-1086
42. Cantini M, Massimino ML, Rapizzi E, Rossini K, Catani C, Dalla Libera L, Carraro U 1995 Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor (s) released by activated monocytes. Biochem Biophys Res Commun 216:49-53
43. Massimino ML, Rapizzi E, Cantini M, Libera LD, Mazzoleni F, Arslan P, Carraro U 1997 ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem Biophys Res Commun 235:754-759
44. Cantini M, Carraro U 1995 Macrophage-released factor stimulates selectively myogenic cells in primary muscle culture. J Neuropathol Exp Neurol 54:121-128
45. Merly F, Lescaudron L, Rouaud T, Crossin F, Gardahaut MF 1999 Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22:724-732
46. Segal S, Narayanan R, Dalton JT 2006 Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery. Expert Opin Investig Drugs 15:377-387
47. Cadilla R, Turnbull P 2006 Selective androgen receptor modulators in drug discovery: medicinal chemistry and therapeutic potential. Curr Top Med Chem 6:245-270
48. Wilflingseder D, Mullauer B, Schramek H, Banki Z, Pruenster M, Dierich MP, Stoiber H 2004 HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J Immunol 173:7497-7505
49. Cohen PS, Schmidtmayerova H, Dennis J, Dubrovsky L, Sherry B, Wang H, Bukrinsky M, Tracey KJ 1997 The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med 3:339-346
50. Coletti D, Moresi V, Adamo S, Molinaro M, Sassoon D 2005 Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration. Genesis 43:120-128
51. Kim SO, Ono K, Tobias PS, Han J 2003 Orphan nuclear receptor Nur77 is involved in caspase-independent macrophage cell death. J Exp Med 197:1441-1452
52. Keating NL, O'Malley AJ, Smith MR 2006 Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24:4448-4456
53. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS 2005 Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352:154-164
54. Smith MR 2004 Osteoporosis and obesity in men receiving hormone therapy for prostate cancer. J Urol 172:S52-S56; discussion S56-S57